Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Earl Martin Douglas currently holds 449,324 shares of BIOMIMETIC THERAPEUTICS, INC. (BMTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Earl Martin Douglas has been a net seller of BMTI stock. They have purchased $62.5K and sold $446.9K worth of shares.
Earl Martin Douglas's most recent insider trade was on Aug 21, 2024, when they sold 28,310 shares at $2.79 per share.
Earl Martin Douglas serves as Executive at BIOMIMETIC THERAPEUTICS, INC. (BMTI). They have executed 50 insider transactions totaling $509.4K over their tenure at the company.
Earl Martin Douglas holds the position of Executive at BIOMIMETIC THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Earl Martin Douglas has shown a selling trading pattern, with $62.5K in total purchases and $446.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Earl Martin Douglas was on Jan 13, 2010, when they sold $151.3K worth of BMTI shares. This transaction involved 12,500 shares at $12.10 per share.
Earl Martin Douglas currently owns 449,324 shares of BIOMIMETIC THERAPEUTICS, INC. (BMTI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Earl Martin Douglas's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Earl Martin Douglas has 50 Form 4 filings on record as an insider at BIOMIMETIC THERAPEUTICS, INC..
Set alerts for Earl Martin Douglas and 40,000+ other insiders.